Full Press Release Details
Accessibility: Skip TopNav
Summit Corporation PLC : Holding(s) in Company (amendment)
April 27, 2012 11:07 ET
Summit Therapeutics plc
Summit Therapeutics plc
This announcement replaces RNS Number HUG1606130, which was released at 7.01 a.m. on 26 April 2012. There is no change in the underlying number of shares held but the percentage of voting rights has been amended from 3.08% to 3.06%.
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i | ||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Summit plc | |
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||
| An acquisition or disposal of voting rights | X | |
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||
| An event changing the breakdown of voting rights | ||
| Other (please specify): | ||
| 3. Full name of person(s) subject to the notification obligation: iii | Polar Capital Global Healthcare Growth and Income Trust Plc | |
| 4. Full name of shareholder(s) (if different from 3.): iv | ||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v | 25 th April 2012 | |
| 6. Date on which issuer notified: | 25 th April 2012 | |
| 7. Threshold(s) that is/are crossed or reached: vi, vii | 3% |
| 8. Notified details: | |||||||
| A: Voting rights attached to shares viii, ix | |||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | |||
| Direct | Direct xi | Indirect xii | Direct | Indirect | |||
| GB00B02T3K57 | 0 | 10,833,334 | 3.06% | ||||
| B: Qualifying Financial Instruments | |||||||
| Resulting situation after the triggering transaction | |||||||
| Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | |||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||
| Resulting situation after the triggering transaction | |||||||
| Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | ||
| Nominal | Delta | ||||||
| Total (A+B+C) | |||||||
| Number of voting rights | Percentage of voting rights | ||||||
| 10,833,334 | 3.06% |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | |
| Proxy Voting: | |
| 10. Name of the proxy holder: | |
| 11. Number of voting rights proxy holder will cease to hold: | |
| 12. Date on which proxy holder will cease to hold voting rights: | |
| 13. Additional information: | |
| 14. Contact name: | Polar Capital LLP - Operations Department |
| 15. Contact telephone number: | +44 (0)207 227 2700 |